ALBERTDAVD vs BAFNAPH: Stock Comparison

ALBERT DAVID vs BAFNAPHUpdated 4 Sept 26, 4:08 PM ISTNSE & company filings

BAFNAPH is the larger company by market capitalisation. ALBERT DAVID shows a higher dividend yield and lower leverage, while BAFNAPH shows a lower P/E, a higher ROE and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

ALBERTDAVD leads 5; BAFNAPH leads 8 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

ALBERTDAVDBAFNAPH

Valuation lens

What price are you paying?

Market CapContext only
₹493 Cr
₹702 Cr
P/E RatioBAFNAPH has the lower reading
20.47x
0x
P/B RatioBAFNAPH has the lower reading
1.18x
0x
EPSALBERTDAVD has the higher reading
₹56.07
₹0.03
Book ValueContext only
₹686.04
₹40.64
Dividend YieldALBERTDAVD has the higher reading
0.58%
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
BAFNAPH is the larger company
₹702 Cr vs ₹493 Cr
P/E Ratio
BAFNAPH has a lower P/E
0x vs 20.47x
P/B Ratio
BAFNAPH has a lower P/B
0x vs 1.18x
EPS
ALBERTDAVD has higher earnings per share
₹56.07 vs ₹0.03
Dividend Yield
ALBERTDAVD has a higher dividend yield
0.58% vs 0%
Revenue Growth (TTM YoY)
BAFNAPH has faster revenue growth
15.4% vs 14.6%
EPS Growth (TTM YoY)
BAFNAPH has faster EPS growth
95% vs 0%
Qtr Sales Growth
ALBERTDAVD has stronger quarterly sales growth
-69.62% vs -82.35%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricALBERTDAVDBAFNAPH
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricALBERTDAVDBAFNAPH
Live Price₹860.25₹174.58
Day Change-1.14%-10%
Volume3,3392.84 L
52-Week High₹931.85₹213.36
52-Week Low₹579.9₹94.77
Distance from 52W High-7.68%-18.18%

Valuation

MetricALBERTDAVDBAFNAPH
Market Cap₹493 Cr₹702 Cr
P/E Ratio20.47x0x
P/B Ratio1.18x0x
EPS₹56.07₹0.03
Book Value₹686.04₹40.64
Dividend Yield0.58%0%

Growth

MetricALBERTDAVDBAFNAPH
Revenue Growth (TTM YoY)14.6%15.4%
EPS Growth (TTM YoY)0%95%
Qtr Sales Growth-69.62%-82.35%
Qtr Profit Growth2,240.75%-99.32%

Profitability & Leverage

MetricALBERTDAVDBAFNAPH
ROE-0.38%11.54%
ROCE-2.14%11.12%
Net Margin-0.45%7.37%
Operating Margin0.95%9.71%
Debt to Equity0.07x0.39x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricALBERTDAVDBAFNAPH
Promoter Holding62.24%75%
FII Holding0.57% 0.01 pp9.34%
DII Holding1.64% 0.02 pp0%
Public Holding35.56% 0.04 pp15.66%

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: ALBERT DAVID and BAFNAPH.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.